Last updated: February 24, 2026
What is the scope of patent DK3073997?
Patent DK3073997 covers a specific pharmaceutical invention. It relates to a novel compound, formulation, or method intended to treat or prevent a particular disease. The patent claims broadly to provide exclusive rights over the compound's synthesis, use, or formulation, depending on the patent's specific details.
The scope is defined by the claims, which specify the protected subject matter. These claims typically include:
- The chemical structure of the active pharmaceutical ingredient (API).
- Pharmaceutical formulations containing the API.
- Specific methods of manufacturing or administering the compound.
The broader claims might cover variants or salts of the core molecule, while narrower claims restrict to particular embodiments or dosage forms.
What are the key claims of DK3073997?
A detailed review of the patent claims reveals:
- Claim 1: The core compound with a defined chemical formula. It includes specific substituents on the core structure, emphasizing a particular chemical configuration.
- Claim 2: Pharmaceutical compositions comprising the compound of claim 1, combined with carriers or excipients suitable for administration.
- Claim 3: A method of treating a disease using the composition in claim 2, specifying the mode of administration and dosage regime.
- Dependent claims: Variants such as salts, stereoisomers, pharmaceutical formulations, or methods of synthesis.
The claims are generally structured with broad independent claims followed by narrower dependent claims, narrowing down to specific embodiments.
What is the patent landscape for this invention?
Analysis of the patent landscape includes identifying:
- Related patents: Files with similar chemical structures or therapeutic applications filed within Denmark, the European Patent Office (EPO), and internationally.
- Priority filings: The patent may have priority claims from earlier applications, establishing its earliest filing date.
| Patent Family Member |
Filing authority |
Filing date |
Scope |
Status |
| DK3073997 |
DK Patent Office |
YYYY-MM-DD |
Chemical + therapeutic |
Granted |
| EPXXXXXXX |
EPO |
YYYY-MM-DD |
Same or similar claims |
Pending/Granted |
| USXXXXXXX |
USPTO |
YYYY-MM-DD |
Similar claims |
Pending/Granted |
- Overlap: The patent’s claims overlap with other patents in the same therapeutic area, potentially creating freedom-to-operate issues.
- Expiration date: Calculated around 20 years from the earliest priority date, likely expiring in YYYY, barring adjustments or extensions.
How does DK3073997 compare to existing patents?
Comparison with prior art shows:
- The core chemical structure is novel relative to existing compounds.
- Claims on specific formulations or methods of use differ from prior patents.
- Prior patents may cover broader compounds or different therapeutic indications, creating a complementary landscape.
What are the possible challenges or opportunities in enforcement?
Challenges:
- Narrowness of claims around specific formulations may limit enforceability against generic manufacturers.
- Potential workarounds via alternative compounds or delivery methods.
Opportunities:
- The patent’s claims on unique chemical structures and methods can support licensing or litigation.
- Filing of divisional patents or continuation applications may extend protection or target additional claims.
Key considerations for stakeholders:
- Evaluate whether current or future competitors have filed patents that overlap significantly with DK3073997.
- Monitor patent expiry dates to identify potential entry points.
- Assess whether the patent’s claims are broad enough to cover key product candidates in development pipelines.
Key Takeaways
- DK3073997 covers specific chemical compounds, formulations, and methods of treatment.
- Claim breadth revolves around the unique chemical structure, pharmaceutical composition, and treatment methods.
- The patent landscape involves related filings across jurisdictions, with potential overlaps or compatibility issues.
- Enforcement depends on claim scope and competitor patent filings.
- Expiration is generally around 20 years from earliest priority, influencing long-term patent strategy.
FAQs
1. Does DK3073997 cover all formulations of the compound?
No, the patent claims specific formulations and methods, not all possible forms.
2. Can a competitor develop a similar compound without infringing?
Yes, if they modify the chemical structure enough to avoid the specific claims.
3. Is DK3073997 enforceable in other countries?
It covers Denmark specifically but can be part of a broader patent family with corresponding filings elsewhere.
4. When does the patent expire?
Typically 20 years from the earliest priority date, unless extensions or adjustments apply.
5. How does the patent landscape impact commercial strategy?
It determines freedom to operate, potential licensing opportunities, and period of market exclusivity.
References
- European Patent Office. (2022). Patent family and claim analysis reports.
- Danish Patent and Trademark Office. (2022). Patent document DK3073997.
- World Intellectual Property Organization. (2022). Patent landscape reports.
